NASDAQ: NEPTNeptune Wellness Solutions Inc Stock
$1.42+0.07 (+5.19%)
Updated Sep 27, 2023
NEPT Price
$1.42
Fair Value Price
$13.69
Market Cap
$856.18k
52 Week Low
$1.31
52 Week High
$76.80
P/E
-0.01x
P/B
-0.05x
P/S
0.05x
PEG
N/A
Dividend Yield
N/A
Revenue
$46.97M
Earnings
-$100.71M
Gross Margin
3.8%
Operating Margin
-204.4%
Profit Margin
-214.4%
Debt to Equity
-3.59
Operating Cash Flow
-$27M
Beta
1.17
Next Earnings
Nov 13, 2023
Ex-Dividend
N/A
Next Dividend
N/A
NEPT Overview
Neptune Wellness Solutions Inc. operates as an integrated health and wellness company in Canada, the United States, and internationally. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe brands. The company also offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, including nutraceuticals, beauty and personal care products, and organic foods and beverages. In addition, it is involved in the extraction, purification, formulation, and manufacturing of health and wellness products. Further, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NEPT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NEPT ($1.42) is undervalued by 89.63% relative to our estimate of its Fair Value price of $13.69 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
NEPT ($1.42) is significantly undervalued by 89.63% relative to our estimate of its Fair Value price of $13.69 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
NEPT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more NEPT due diligence checks available for Premium users.
Be the first to know about important NEPT news, forecast changes, insider trades & much more!
NEPT News
Valuation
NEPT fair value
Fair Value of NEPT stock based on Discounted Cash Flow (DCF)
Price
$1.42
Fair Value
$13.69
Undervalued by
89.63%
NEPT ($1.42) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NEPT ($1.42) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NEPT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
NEPT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.01x
Industry
26.94x
Market
13.45x
NEPT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.05x
Industry
1.99x
NEPT's financial health
Profit margin
Revenue
$10.6M
Net Income
-$9.8M
Profit Margin
-92.2%
NEPT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NEPT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$30.5M
Liabilities
$66.0M
Debt to equity
-3.59
NEPT's short-term liabilities ($48.43M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NEPT's short-term assets ($23.40M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NEPT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NEPT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$5.3M
Investing
-$3.7k
Financing
$4.3M
NEPT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
NEPT vs Pharmaceutical Stocks
Neptune Wellness Solutions Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.